Skip to main content
Mark Jarrett wearing a red tie
Senior Vice President and Chief Quality Officer
Northwell Health

Associate Chief Medical Officer
Northwell Health

Professor, Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

As chief quality officer for Northwell Health, Mark P. Jarrett, MD, MBA, is responsible for system-wide initiatives in quality and safety.

Dr. Jarrett is also Northwell’s associate chief medical officer and a professor of medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.

He previously served as chief medical officer and DIO at Staten Island University Hospital (SIUH). Prior to that appointment, Dr. Jarrett was director of Rheumatology at SIUH from 1982-1999. Dr. Jarrett has extensive research experience, and has been published on the subject of the immune response in systemic lupus erythematosus, quality and cybersecurity in health care.

Dr. Jarrett is board certified in internal medicine and rheumatology. He is a Fellow of the American College of Physicians and the American College of Rheumatology, and past president of the Richmond County Medical Society.

Dr. Jarrett earned his medical degree from New York University School of Medicine. He completed his residency in internal medicine at Montefiore Medical Center, and a fellowship at Montefiore Medical Center and Albert Einstein College of Medicine.

Dr. Jarrett also holds an MBA from Wagner College and an MS in Medical Informatics from Northwestern University. He is also a certified Healthcare Information Security and Privacy Practitioner (HCISPP)

The latest news for Mark Jarrett, MD
Mark Jarrett, MD, comments about populating EHRs with content in this Modern Healthcare report.
New York State Troopers Police Benevolent Association honors Northwell Health's Dr. Mark Jarrett and Ronda Gross.
Northwell Health Dr. Mark Jarrett and Ronda Gross, RN, have each been named Doctor Chandler award winners by the New York State Troopers Police Benevolent Association.
Mark Jarrett, MD, talks to Newsday about the expanding use of IVIg.